Cargando…

Risk of regional recurrence in triple-negative breast cancer patients: a Dutch cohort study

Triple-negative breast cancer is associated with early recurrence and low survival rates. Several trials investigate the safety of a more conservative approach of axillary treatment in clinically T1-2N0 breast cancer. Triple-negative breast cancer comprises only 15 % of newly diagnosed breast cancer...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Roozendaal, Lori M., Smit, Leonie H. M., Duijsens, Gaston H. N. M., de Vries, Bart, Siesling, Sabine, Lobbes, Marc B. I., de Boer, Maaike, de Wilt, Johannes H. W., Smidt, Marjolein L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2016
Materias:	Clinical Trial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4837212/ https://www.ncbi.nlm.nih.gov/pubmed/27013474 http://dx.doi.org/10.1007/s10549-016-3757-4

Ejemplares similares

De-escalation of axillary surgery in breast cancer patients treated in the neoadjuvant setting: a Dutch population-based study
por: Simons, J. M., et al.
Publicado: (2020)

Clinical tumor stage is the most important predictor of pathological complete response rate after neoadjuvant chemotherapy in breast cancer patients
por: Goorts, Briete, et al.
Publicado: (2017)

Impact of analysis of the sentinel lymph node by one-step nucleic acid amplification (OSNA) compared to conventional histopathology on axillary and systemic treatment: data from the Dutch nationwide cohort of breast cancer patients
por: van Haaren, Elisabeth R. M., et al.
Publicado: (2023)

Three-Dimensional Breast Radiotherapy and the Elective Radiation Dose at the Sentinel Lymph Node Site in Breast Cancer
por: van Roozendaal, Lori M., et al.
Publicado: (2015)

Pathologic complete response of ductal carcinoma in situ to neoadjuvant systemic therapy in HER2-positive invasive breast cancer patients: a nationwide analysis
por: Ploumen, Roxanne A. W., et al.
Publicado: (2023)

The value of completion axillary treatment in sentinel node positive breast cancer patients undergoing a mastectomy: a Dutch randomized controlled multicentre trial (BOOG 2013-07)
por: van Roozendaal, L. M., et al.
Publicado: (2015)

Sentinel lymph node biopsy can be omitted in DCIS patients treated with breast conserving therapy
por: van Roozendaal, L. M., et al.
Publicado: (2016)

Clinically node negative breast cancer patients undergoing breast conserving therapy, sentinel lymph node procedure versus follow-up: a Dutch randomized controlled multicentre trial (BOOG 2013-08)
por: van Roozendaal, L. M., et al.
Publicado: (2017)

The supplemental value of mammographic screening over breast MRI alone in BRCA2 mutation carriers
por: Obdeijn, Inge-Marie, et al.
Publicado: (2020)

Clinical Trial Highlights – Interventions Promoting Physical Activity in Parkinson’s Disease
por: Oosterhof, Thomas H., et al.
Publicado: (2023)

Impact of the suspension and restart of the Dutch breast cancer screening program on breast cancer incidence and stage during the COVID-19 pandemic
por: Eijkelboom, Anouk H., et al.
Publicado: (2021)

One year effectiveness of an app‐based treatment for urinary incontinence in comparison to care as usual in Dutch general practice: A pragmatic randomised controlled trial over 12 months
por: Loohuis, Anne MM, et al.
Publicado: (2022)

Different outcome in node-positive breast cancer patients found by axillary ultrasound or sentinel node procedure
por: Verheuvel, Nicole C., et al.
Publicado: (2017)

Changes in breast cancer treatment during the COVID-19 pandemic: a Dutch population-based study
por: Eijkelboom, Anouk H., et al.
Publicado: (2022)

Breast cancer outcome in relation to bone mineral density and bisphosphonate use: a sub-study of the DATA trial
por: van Hellemond, Irene E. G., et al.
Publicado: (2020)

Clinical decision trees support systematic evaluation of multidisciplinary team recommendations
por: Hendriks, Mathijs P., et al.
Publicado: (2020)

Defining the noninferiority margin and analysing noninferiority: An overview
por: Althunian, Turki A., et al.
Publicado: (2017)

Clinical and genomic assessment of PD-L1 SP142 expression in triple-negative breast cancer
por: Ahn, Sung Gwe, et al.
Publicado: (2021)

Repeat breast-conserving treatment of ipsilateral breast cancer recurrence: a nationwide survey amongst breast surgeons and radiation oncologists in the Netherlands
por: Walstra, Coco J. E. F., et al.
Publicado: (2021)

Neoadjuvant carboplatin in triple-negative breast cancer: results from NACATRINE, a randomized phase II clinical trial
por: de Pádua Souza, Cristiano, et al.
Publicado: (2023)

Patients’ perceptions of 70-gene signature testing: commonly changing the initial inclination to undergo or forego chemotherapy and reducing decisional conflict
por: van Steenhoven, Julia E. C., et al.
Publicado: (2020)

The initial hormone receptor/HER2 subtype is the main determinator of subtype discordance in advanced breast cancer: a study of the SONABRE registry
por: Meegdes, Marissa, et al.
Publicado: (2022)

Preserving fertility in young women undergoing chemotherapy for early breast cancer; the Maastricht experience
por: Vriens, Ingeborg J. H., et al.
Publicado: (2020)

Bacterial lysate add‐on therapy to reduce exacerbations in severe asthma: A double‐blind placebo‐controlled trial
por: de Boer, Geertje M., et al.
Publicado: (2021)

Two decades of external peer review of cancer care in general hospitals; the Dutch experience
por: Kilsdonk, Melvin J., et al.
Publicado: (2015)

Treatment of anastomotic leakage after rectal cancer resection: The TENTACLE–Rectum study
por: van Workum, Frans, et al.
Publicado: (2020)

Thyroid function alters during neoadjuvant chemotherapy in breast cancer patients: results from the NEOZOTAC trial (BOOG 2010-01)
por: de Groot, S., et al.
Publicado: (2015)

Analysis of patients without and with an initial triple-negative breast cancer diagnosis in the phase 3 randomized ASCENT study of sacituzumab govitecan in metastatic triple-negative breast cancer
por: O’Shaughnessy, Joyce, et al.
Publicado: (2022)

Metronomic chemotherapy (mCHT) in metastatic triple-negative breast cancer (TNBC) patients: results of the VICTOR-6 study
por: Cazzaniga, M. E., et al.
Publicado: (2021)

Long-term effects of the interruption of the Dutch breast cancer screening program due to COVID-19: A modelling study
por: Poelhekken, Keris, et al.
Publicado: (2023)

Epistemic in/justice in patient participation. A discourse analysis of the Dutch ME/CFS Health Council advisory process
por: de Boer, Marjolein Lotte
Publicado: (2021)

Taste and smell perception and quality of life during and after systemic therapy for breast cancer
por: de Vries, Y. C., et al.
Publicado: (2018)

Strong CD8+ lymphocyte infiltration in combination with expression of HLA class I is associated with better tumor control in breast cancer patients treated with neoadjuvant chemotherapy
por: de Groot, A. F., et al.
Publicado: (2019)

The clinical impact of molecular breast imaging in women with proven invasive breast cancer scheduled for breast-conserving surgery
por: Collarino, Angela, et al.
Publicado: (2018)

Quality of Recovery and Innate Immune Homeostasis in Patients Undergoing Low-pressure Versus Standard-pressure Pneumoperitoneum During Laparoscopic Colorectal Surgery (RECOVER): A Randomized Controlled Trial
por: Albers, Kim I., et al.
Publicado: (2022)

Quantifying culture gaps between physicians and managers in Dutch hospitals: a survey
por: Klopper-Kes, Hanneke AHJ, et al.
Publicado: (2010)

Postoperative mortality risk assessment in colorectal cancer: development and validation of a clinical prediction model using data from the Dutch ColoRectal Audit
por: de Nes, Lindsey C. F., et al.
Publicado: (2022)

A randomized, placebo-controlled phase 2 study of paclitaxel in combination with reparixin compared to paclitaxel alone as front-line therapy for metastatic triple-negative breast cancer (fRida)
por: Goldstein, Lori J., et al.
Publicado: (2021)

Phase 1b dose-finding study of motesanib with docetaxel or paclitaxel in patients with metastatic breast cancer
por: De Boer, Richard H., et al.
Publicado: (2012)

In‐hospital cost analysis of prostatic artery embolization compared with transurethral resection of the prostate: post hoc analysis of a randomized controlled trial
por: Müllhaupt, Gautier, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_bp8ngl7bq6hprc2p0du6nef6tk